https://www.prnewswire.com/news-releases/alkermes-to-present-data-on-nemvaleukin-alfa-at-the-american-society-of-clinical-oncology-gastrointestinal-cancers-symposium-301461525.html
Alkermes to Present Data on Nemvaleukin Alfa at the American Society of Clinical Oncology...
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to nemvaleukin alfa (nemvaleukin), the company's novel,...
https://dukespace.lib.duke.edu/items/2e9ffd14-02b8-40dd-84fc-c8ee0a602563
Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in...